NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 59 filers reported holding NEUBASE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $32,000 | -63.2% | 82,199 | -0.4% | 0.00% | – |
| Q2 2022 | $87,000 | -43.9% | 82,499 | +0.4% | 0.00% | – |
| Q1 2022 | $155,000 | -33.2% | 82,199 | -0.2% | 0.00% | – |
| Q4 2021 | $232,000 | -38.6% | 82,391 | -21.4% | 0.00% | – |
| Q3 2021 | $378,000 | -28.0% | 104,796 | -4.5% | 0.00% | – |
| Q2 2021 | $525,000 | -31.8% | 109,685 | +5.2% | 0.00% | – |
| Q1 2021 | $770,000 | +23.2% | 104,235 | +16.6% | 0.00% | – |
| Q4 2020 | $625,000 | -5.0% | 89,371 | +3.1% | 0.00% | – |
| Q3 2020 | $658,000 | +439.3% | 86,724 | +523.9% | 0.00% | – |
| Q2 2020 | $122,000 | – | 13,901 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 906,445 | $3,272,000 | 1.04% |
| Greenlight Capital | 2,727,027 | $9,844,000 | 0.66% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 407,500 | $1,471,000 | 0.54% |
| CM Management, LLC | 75,000 | $271,000 | 0.20% |
| Stonepine Capital Management, LLC | 109,742 | $396,000 | 0.18% |
| GSA CAPITAL PARTNERS LLP | 351,178 | $1,268,000 | 0.13% |
| PERKINS CAPITAL MANAGEMENT INC | 21,000 | $76,000 | 0.05% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 311,000 | $1,123,000 | 0.03% |
| Polar Asset Management Partners Inc. | 634,618 | $2,291,000 | 0.02% |
| Point72 Asset Management, L.P. | 1,250,000 | $4,513,000 | 0.02% |